CORCEPT THERAPEUTICS INC
CORTUS売上高
$761M
百万USD
営業利益
$45M
百万USD
純利益
$100M
百万USD
ROE
15.4%
最新FY
EPS
$0.82
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $79M | $23M | $0.18 |
| FY2021 | Q2 | $92M | $27M | $0.21 |
| FY2021 | Q3 | $96M | $30M | $0.24 |
| FY2021 | FY | $366M | $113M | $0.89 |
| FY2022 | Q1 | $94M | $23M | $0.20 |
| FY2022 | Q2 | $103M | $27M | $0.24 |
| FY2022 | Q3 | $102M | $35M | $0.30 |
| FY2022 | FY | $402M | $101M | $0.87 |
| FY2023 | Q1 | $106M | $16M | $0.14 |
| FY2023 | Q2 | $118M | $28M | $0.25 |
| FY2023 | Q3 | $124M | $31M | $0.28 |
| FY2023 | FY | $482M | $106M | $0.94 |
| FY2024 | Q1 | $147M | $28M | $0.25 |
| FY2024 | Q2 | $164M | $35M | $0.32 |
| FY2024 | Q3 | $183M | $47M | $0.41 |
| FY2024 | FY | $675M | $141M | $1.23 |
| FY2025 | Q1 | $157M | $21M | $0.17 |
| FY2025 | Q2 | $194M | $35M | $0.29 |
| FY2025 | Q3 | $208M | $20M | $0.16 |
| FY2025 | FY | $761M | $100M | $0.82 |
| FY2026 | Q1 | $165M | $-32M | $-0.30 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $251M | $306M | $354M | $366M | $402M | $482M | $675M | $761M |
| 営業利益 | $10M | $53M | $89M | $112M | $128M | $124M | $113M | $107M | $137M | $45M |
| 純利益 | $8M | $129M | $75M | $94M | $106M | $113M | $101M | $106M | $141M | $100M |
| 総資産 | $69M | $221M | $312M | $412M | $572M | $424M | $583M | $622M | $841M | $837M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $41M | $191M | $276M | $371M | $523M | $376M | $502M | $507M | $680M | $648M |
| 営業CF | - | - | $116M | $136M | $152M | $168M | $120M | $127M | $198M | $142M |
| EPS | - | $1.04 | $0.60 | $0.77 | $0.85 | $0.89 | $0.87 | $0.94 | $1.23 | $0.82 |
| BPS | $0.37 | $1.66 | $2.40 | $3.24 | $4.46 | $3.55 | $4.65 | $4.89 | $6.44 | $6.09 |
| ROE | 19.7% | 67.6% | 27.3% | 25.4% | 20.3% | 29.9% | 20.2% | 20.9% | 20.8% | 15.4% |